Hap Trading, LLC Evolus, Inc. Call Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$10.45 - $13.76 $1.23 Million - $1.62 Million	-117,900 Reduced 58.22%	84,600 $25,000
Q1 2024 May 13, 2024	BUY	$9.99 - $14.91 $2.02 Million - $3.02 Million	202,500 New	202,500 $116 Million
Q3 2021 Nov 10, 2021	BUY	$7.36 - $13.67 $132,480 - $246,060	18,000 Added 101.12%	35,800 $10,000
Q2 2021 Aug 11, 2021	BUY	$8.42 - $13.96 $8,420 - $13,960	1,000 Added 5.95%	17,800 $42,000
Q1 2021 May 14, 2021	SELL	$3.2 - $16.51 $17,600 - $90,805	-5,500 Reduced 24.66%	16,800 $107,000
Q4 2020 Feb 16, 2021	BUY	$2.92 - $4.84 $16,644 - $27,588	5,700 Added 34.34%	22,300 $6,000
Q3 2020 Nov 13, 2020	SELL	$3.03 - $5.48 $43,329 - $78,364	-14,300 Reduced 46.28%	16,600 $16,000
Q2 2020 Aug 10, 2020	BUY	$3.53 - $6.17 $63,893 - $111,677	18,100 Added 141.41%	30,900 $22,000
Q1 2020 May 08, 2020	BUY	$3.53 - $12.21 $45,184 - $156,288	12,800 New	12,800 $10,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $611M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.